Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.

Tandler C, Heitmann JS, Michel TM, Marconato M, Jaeger SU, Tegeler CM, Denk M, Richter M, Oezbek MT, Maringer Y, Schroeder SM, Schneiderhan-Marra N, Wiesmüller KH, Bitzer M, Ruetalo N, Schindler M, Meisner C, Fischer I, Rammensee HG, Salih HR, Walz JS

Open source

DOI: 10.1016/j.ijid.2023.11.009
Published: 2024 Feb
Container: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ijid.2023.11.009,
  title = {Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.},
  author = {Tandler C and Heitmann JS and Michel TM and Marconato M and Jaeger SU and Tegeler CM and Denk M and Richter M and Oezbek MT and Maringer Y and Schroeder SM and Schneiderhan-Marra N and Wiesmüller KH and Bitzer M and Ruetalo N and Schindler M and Meisner C and Fischer I and Rammensee HG and Salih HR and Walz JS},
  year = {2024},
  journal = {International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases},
  doi = {10.1016/j.ijid.2023.11.009},
  url = {https://doi.org/10.1016/j.ijid.2023.11.009}
}

RIS

TY  - JOUR
TI  - Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.
AU  - Tandler C
AU  - Heitmann JS
AU  - Michel TM
AU  - Marconato M
AU  - Jaeger SU
AU  - Tegeler CM
AU  - Denk M
AU  - Richter M
AU  - Oezbek MT
AU  - Maringer Y
AU  - Schroeder SM
AU  - Schneiderhan-Marra N
AU  - Wiesmüller KH
AU  - Bitzer M
AU  - Ruetalo N
AU  - Schindler M
AU  - Meisner C
AU  - Fischer I
AU  - Rammensee HG
AU  - Salih HR
AU  - Walz JS
PY  - 2024
JO  - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
DO  - 10.1016/j.ijid.2023.11.009
UR  - https://doi.org/10.1016/j.ijid.2023.11.009
ER  -

APA

C, T., JS, H., TM, M., M, M., SU, J., CM, T., M, D., M, R., MT, O., Y, M., SM, S., N, S., KH, W., M, B., N, R., M, S., C, M., I, F., HG, R., HR, S., & JS, W. (2024). Long-term efficacy of the peptide-based COVID-19 T cell activator CoVac-1 in healthy adults.. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. https://doi.org/10.1016/j.ijid.2023.11.009

Source records

pubmed · retrieved 2026-09-25T20:05:45.140Z